Dynamic analysis of GS‐NS0 cells producing a recombinant monoclonal antibody during fed‐batch culture
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
In this study we have analyzed the dynamic covariation of the mammalian cell proteome with respect to functional phenotype during fed‐batch culture of NS0 murine myeloma cells producing a recombinant IgG 4 monoclonal antibody. GS‐NS0 cells were cultured in duplicate 10 L bioreactors (36.5°C, 15% DOT, pH 7.0) for 335 h and supplemented with a continuous feed stream after 120 h. Cell‐specific growth rate declined continuously after 72 h of culture. Cell‐specific recombinant monoclonal antibody production rate (qP) varied sixfold through culture. Whilst qP correlated with relative recombinant heavy chain mRNA abundance up to 216 h, qP subsequently declined, independent of recombinant heavy chain or light chain mRNA abundance. GS‐NS0 cultures were sampled at 48 h intervals between 24 and 264 h of culture for proteomic analyses. Total protein abundance and nascent polypeptide synthesis was determined by 2D PAGE of unlabeled proteins visualized by SYPRO® Ruby and autoradiography of 35 S‐labeled polypeptides, respectively. Covariation of nascent polypeptide synthesis and abundance with biomass‐specific cell growth, glucose and glutamate consumption, lactate and Mab production rates were then examined using two partial least squares regression models. Most changes in polypeptide synthesis or abundance for proteins previously identified by mass spectrometry were positively correlated with biomass‐specific growth rate. We conclude that the substantial transitions in cell physiology and qP that occur during culture utilize a relatively constant complement of the most abundant host cell machines that vary primarily with respect to induced changes in cell growth rate. Biotechnol. Bioeng. 2007;97: 410–424. © 2006 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032 · cited 1×
“Whilst systematic optimization of media formulation and rational design of feeding regimes have facilitated increased accumulation of cellular biomass in vitro (Wurm, 2004), cell-engineering strategies to improve qP have proven intractable (Dinnis and James, 2005).”
BackgroundSmales, C. M., Dinnis, D. M., Stansfield, S. H., Alete, D., Sage, E. A., Birch, J. R., Racher, A. J., Marshall, C. T., & James, D. C. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20272 · Cited by 119
Self-citation
Cited by
Advances in recombinant antibody manufacturing
Kunert, R., & Reinhart, D. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7388-9 · Cited by 417
Doolan, P., Meleady, P., Barron, N., Henry, M., Gallagher, R., Gammell, P., Melville, M., Sinacore, M., McCarthy, K., Leonard, M., et al. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22670 · Cited by 84
Detailed understanding of enhanced specific antibody productivity in NS0 myeloma cells
Khoo, S. H. G., & Al‐Rubeai, M. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22041 · Cited by 38
“A similar phenomenon was also reported in the latter stages of a fed-batch culture of NS0 cells (Stansfield et al., 2007) where the cell volume continued to increase despite a decrease in cell protein content.”
ResultCarlage, T., Kshirsagar, R., Zang, L., Janakiraman, V., Hincapie, M., Lyubarskaya, Y., Weiskopf, A., & Hancock, W. S. (2012) · Biotechnology Progress · doi:10.1002/btpr.1534 · Cited by 38
Metadata
- Authors
- Stansfield, S. H., Allen, E. E., Dinnis, D. M., Racher, A. J., Birch, J. R., & James, D. C.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2006-11-17
- Volume
- 97
- Issue
- 2
- Pages
- 410-424
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2134217080
- Cited by
- 44
- References
- 2
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.